The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1624
May 17, 2021
View Complete Issue         Table of Contents 2019 
Antibacterial Drugs for Lyme Disease
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Antibacterial Drugs for Lyme Disease
May 17, 2021 (Issue: 1624)
Lyme disease in the US is caused by the spirochete Borrelia burgdorferi, which is transmitted to humans by Ixodes scapularis (blacklegged [deer] tick) and I. pacificus (western blacklegged tick). Most cases of Lyme disease occur in late spring...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Antibacterial Drugs for Lyme Disease
Article code: 1624a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.